Ads
related to: current research on stem cells and diabetes- Safety Data
Safety Info & Side Effects Data For
US Healthcare Professionals.
- Dosing Data
Dosing Considerations And Data For
US Healthcare Professionals.
- Patient Coverage
With co-pay options available
Search for patient coverage.
- Medication Guidelines
Learn about medication guidelines
For US Healthcare Professionals.
- Safety Data
Search results
Results from the WOW.Com Content Network
A woman has undergone a stem-cell therapy made from her own cells, to treat her type 1 diabetes. Researchers in China discovered the woman did not need to use insulin 75 days after the procedure ...
Stem cells are being explored for use in conservation efforts. Spermatogonial stem cells have been harvested from a rat and placed into a mouse host and fully mature sperm were produced with the ability to produce viable offspring. Currently research is underway to find suitable hosts for the introduction of donor spermatogonial stem cells.
The FDA approved a phase I clinical trial with ViaCyte beta cells derived from human embryonic stem cell for the treatment of diabetes in August 2014. [15] The cells will be delivered in immunoprotective capsules and pre-clinical results in animal models showed remission of symptoms within a few months. [16]
Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that occurs when pancreatic cells (beta cells) are destroyed by the body's immune system. [5] In healthy persons, beta cells produce insulin .
NYSCF was founded in New York City by Susan L. Solomon, a lawyer and entrepreneur, and Mary Elizabeth Bunzel, a former journalist, in 2005 to accelerate stem cell-based approaches to researching and treating type 1 diabetes [3] and in response to the refusal of the administration of President George W. Bush to make a major investment in stem cell research. [1]
Stem cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplantation is a widely used form of stem cell therapy. [26] No other forms of stem cell therapy are in clinical use at this time. Research is underway to potentially use stem cell therapy to treat heart disease, diabetes, and spinal cord ...
Yamanaka developed the method as an alternative to embryonic stem cells, thus circumventing an approach in which embryos would be destroyed. In May 2010, Yamanaka was given "Doctor of Science honorary degree" by Mount Sinai School of Medicine. [22] In September 2010, he was awarded the Balzan Prize for his work on biology and stem cells. [23]
Stem cell tourism is the part of the medical tourism industry in which patients travel to obtain stem cell procedures. [109] The United States has had an explosion of "stem cell clinics". [110] Stem cell procedures are highly profitable for clinics. The advertising sounds authoritative but the efficacy and safety of the procedures is unproven.
Ads
related to: current research on stem cells and diabetes